Hematopoietic Stem Cell Transplantation Complications

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2023-04-14
Clinical Trial Update: Vedolizumab in the Prophylaxis of Intestinal Acute Graft Versus Host Disease (aGVHD) in Participants Undergoing Allogeneic Hematopoietic Stem Cell (Allo-HSCT) Transplantation [Phase 3]
Phase 3 trial evaluating vedolizumab for prevention of intestinal acute graft-versus-host disease in patients undergoing allogeneic hematopo…